Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02339870 · ClinicalTrials.gov registry record · NA

Expressive Writing in Improving the Wellbeing or Comforting Capacity of Caregivers of Patients With Cancer

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT02339870: Completed NA study, sponsored by University of Washington.

NCT02339870 is a NA study that has completed, run by University of Washington. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02339870, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

This randomized clinical trial studies expressive writing in improving the wellbeing or comforting capacity of caregivers of patients with cancer. Expressive writing is a type of intervention that asks people to write about important topics (in this case participants' experience with their spouses'/partners' cancer) and their emotions/feelings surrounding them. Expressive writing, including benefit finding and traumatic disclosure, may be a type of at-home-therapy that caregivers can utilize in an attempt to increase their own wellbeing, offer better comfort to cancer patients, and by association, help cancer patients cope with and manage the cancer experience.

Primary Outcome

Will be reported pre- to post-test for both treatment groups compared to the control group. Repeated measures analysis of variance (ANOVA) within/between interaction will be used.

Interventions

  • OTHER Questionnaire Administration
  • OTHER Sham Intervention
  • OTHER Psychosocial Support for Caregiver

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2015-04
Est. Completion 2016-01
Phase NA
University of Washington

1,048 total trials

What the finished NCT02339870 record still lists

NCT02339870 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT02339870 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02339870 about?

NCT02339870 is a clinical study titled "Expressive Writing in Improving the Wellbeing or Comforting Capacity of Caregivers of Patients With Cancer". This randomized clinical trial studies expressive writing in improving the wellbeing or comforting capacity of caregivers of patients with cancer. Expressive writing is a type of intervention that asks people to write about important topics (in this case participants' experience with their spouses'/...

What is the current status of trial NCT02339870?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-04. Estimated completion is 2016-01.

What interventions are being tested in trial NCT02339870?

The interventions under investigation include: Questionnaire Administration (OTHER), Sham Intervention (OTHER), Psychosocial Support for Caregiver (OTHER).

Who is sponsoring clinical trial NCT02339870?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02339870's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02339870, the US trial registry maintained by the National Library of Medicine. NCT02339870 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.